ArrivoBio
Healthcare & Life Sciences
Recent Finacing
Series B
Recent Raise
$45.3M
Arrivo BioVentures is a biopharmaceutical company developing innovative treatments for major depressive disorder and severe acute pancreatitis, currently advancing two novel drug candidates through clinical trials.
Focus Areas
Biopharmaceuticals
Clinical Trials
Drug Development
Major Depressive Disorder Treatment
Pancreatic Lipase Inhibitor
Acute Pancreatitis
Investors
